|
|
Major Depressive Disorder & Postpartum Depression: Targeting the GABA Deficit
Major depressive disorder (MDD), perinatal depression, and postpartum depression (PPD) are increasingly prevalent conditions that carry an extremely high disease burden. Underdiagnosis and undertreatment of major depressive episodes have led to significant unmet needs for these patient populations. Success of treatment with traditional antidepressants that target monoaminergic deficiencies and imbalances is limited by non- or incomplete therapeutic response as well as delayed onset of action. ... |
|
|
Ready for a Closeup: Differentiating Inadequate Response and Emotional Blunting During Treatment for Major Depressive Disorder
Major depressive disorder (MDD) can have a significant impact on your patients’ lives. However, MDD is not just about feeling “down.” It’s a life-threatening condition that is a leading cause of suicide. Fortunately, there are a variety of effective therapies; however, many patients may experience an inadequate response to treatment and others may have experience anhedonia or reduced emotional responsiveness (ie, emotional blunting) associated with both selective serotonin reuptake inh... |
|
|
Updates on Pain Review: Conversations with the Experts - Steroids, Anti-Depressants, and Anti-Convulsants
Learning Objectives:
Review contraindications to therapy.
Present a framework for best choices based on goals and patient physiology.
Review the pharmacology and physiology of antidepressants.
Review the pharmacology and physiology of steroid medication.
Review the pharmacology and physiology of anticonvulsants.
When preparing to take the pain board examination, both for initial certification and for recertification, there is a dearth of comprehensive educational programming. The Upd... |
|